Literature DB >> 6230751

Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell subset imbalance at sites of disease activity.

G A Rossi, O Sacco, E Cosulich, G Damiani, G Corte, A Bargellesi, C Ravazzoni.   

Abstract

Different lymphocyte subpopulations have been evaluated in bronchoalveolar fluid and blood obtained from six patients with active and six with inactive pulmonary sarcoidosis and from six normal subjects by means of two recently described monoclonal antibodies, 5/9 and MLR4. The percentages of OKT4 positive (helper) and OKT8 positive (suppressor) T cells were also determined. Patients with active sarcoidosis had significantly higher proportions of 5/9 positive T cells in the bronchoalveolar fluid than patients with inactive disease (p less than 0.01) or normal subjects (p less than 0.001). In contrast, the proportions of 5/9 positive blood T cells were similar in the three groups studied. Patients with active sarcoidosis had also a greater proportion proportion of MLR4 positive T lymphocytes in bronchoalveolar fluid than patients with inactive disease or normal subjects (p less than 0.01 for each comparison), but similar proportions of MLR4 positive blood T cells were found in each group. The ratio of 5/9 positive to MLR4 positive T cells was higher in the bronchoalveolar fluid (but not in the blood) in patients with either active or inactive sarcoidosis than in normal subjects. These observations suggest that the MLR4 negative fraction rather than the MLR4 positive fraction of the 5/9 positive T cells is preferentially expanded in the lungs of patients with pulmonary sarcoidosis and may indicate a secondary role for the MLR4 positive T cells in producing lung injury in this disorder. Comparisons of the OKT4 positive and 5/9 positive T cells showed that in patients with active disease most of the lung T lymphocytes expressed both the OKT4 and the 5/9 surface antigens, so the 5/9 monoclonal antibody may be considered a good marker of activity in this disorder. Pulmonary sarcoidosis may be characterised by the preferential expansion of helper T cell subsets at sites of disease activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230751      PMCID: PMC459742          DOI: 10.1136/thx.39.2.143

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  27 in total

1.  Circulating T lymphocytes in Hashimoto's disease: imbalance of subsets and presence of activated cells.

Authors:  G W Canonica; M Bagnasco; G Corte; S Ferrini; O Ferrini; G Giordano
Journal:  Clin Immunol Immunopathol       Date:  1982-06

2.  The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function.

Authors:  B A Keogh; G W Hunninghake; B R Line; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1983-08

3.  Air-space immunoglobulin production and levels in bronchoalveolar lavage fluid of normal subjects and patients with sarcoidosis.

Authors:  J A Rankin; G P Naegel; C E Schrader; R A Matthay; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1983-04

4.  Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis.

Authors:  P Pinkston; P B Bitterman; R G Crystal
Journal:  N Engl J Med       Date:  1983-04-07       Impact factor: 91.245

5.  Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.

Authors:  G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

6.  Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage.

Authors:  B R Line; G W Hunninghake; B A Keogh; A E Jones; G S Johnston; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1981-04

7.  Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation.

Authors:  G Corte; M C Mingari; A Moretta; G Damiani; L Moretta; A Bargellesi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Human T cell subpopulations defined by a monoclonal antibody. II. Evidence for cell cooperation in the response to alloantigens and generation of cytolytic cells.

Authors:  A Moretta; G Corte; M C Mingari; L Moretta
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

9.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

10.  Surface antigens specifically expressed by activated T cells in humans.

Authors:  G Corte; L Moretta; G Damiani; M C Mingari; A Bargellesi
Journal:  Eur J Immunol       Date:  1981-02       Impact factor: 5.532

View more
  9 in total

1.  Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke.

Authors:  F L Petrilli; G A Rossi; A Camoirano; M Romano; D Serra; C Bennicelli; A De Flora; S De Flora
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

2.  Suppression of the alveolitis in pulmonary sarcoidosis by oral corticosteroids.

Authors:  G A Rossi; G B Di Negro; E Balzano; E Cerri; O Sacco; B Balbi; A Venturini; R Ramoino; C Ravazzoni
Journal:  Lung       Date:  1985       Impact factor: 2.584

Review 3.  Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?

Authors:  Lindsay J Celada; Wonder P Drake
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

4.  Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets.

Authors:  A P Greening; P Nunn; N Dobson; M Rudolf; A D Rees
Journal:  Thorax       Date:  1985-04       Impact factor: 9.139

5.  Functional characterization of a regulatory human T-cell subpopulation increasing during autologous MLR.

Authors:  M E Cosulich; A Risso; G W Canonica; A Bargellesi
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

6.  Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset.

Authors:  C Saltini; J R Spurzem; J J Lee; P Pinkston; R G Crystal
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

7.  Evidence for local dendritic cell activation in pulmonary sarcoidosis.

Authors:  Bregje Ten Berge; Alex Kleinjan; Femke Muskens; Hamida Hammad; Henk C Hoogsteden; Rudi W Hendriks; Bart N Lambrecht; Bernt Van den Blink
Journal:  Respir Res       Date:  2012-04-18

8.  Pulmonary alveolar macrophages in molecular epidemiology and chemoprevention of cancer.

Authors:  S De Flora; A Izzotti; F D'Agostini; G A Rossi; R M Balansky
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

9.  Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.

Authors:  Laura E M Eurelings; Jelle R Miedema; Virgil A S H Dalm; Paul L A van Daele; P Martin van Hagen; Jan A M van Laar; Willem A Dik
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.